Home > Giving > Introduction


Fundación Caja Madrid
Obra Social. Fundación 'la Caixa'
Fundación BBVA
Caja Navarra
Fundación Marcelino Botín
Fundación Banco Santander
Fundación Jesús Serra – Catalana Occidente
Hewlett Packard
Amalié Petroquímica
Freesia Group
Fundación Rosae
Caja Canarias, Un Proyecto de Banca Cívica
Caja de Burcos Obra Social
Seve Ballesteros Foundation
Fundación Banco Sabadell


The word cancer refers to a group of pathologies with a genetic character and high complexity that are characterised by an uncontrolled cell growth. In some cases, the tumour cells can spread to other parts of the body through a process known as metastasis. Metastasis remains the leading cause of cancer-associated deaths.

In Spain, cancer is the second-leading cause of death behind cardiovascular disease, having taken the lives of 110,993 people in 2012; this represents 27.5% of the total number of deaths during that period. It is the primary cause of death among men, as well as in the child population (1 to 14 years of age), and the middle-aged (40 - 79 years).

Despite these alarming figures, cancer survival rates have increased to approximately 50% over the past few years. These rates are over 80% for certain types of cancer, such as breast cancer. Twenty years ago these numbers would have been unimaginable, and this is essentially the result of the new drugs derived from scientific research, and the prevention programmes. But there is still a long way to go - to generate new knowledge that can be translated into novel therapies, diagnostic tools and technologies, and better care for patients, will be essential to define the medicine of the future.

Public funding for research is not enough to meet the challenges and ambitious goals set out in our ongoing efforts to better understand and combat the disease. We therefore need to reach out and inform society about the importance of making voluntary and selfless contributions to advance knowledge.


The Spanish National Cancer Research Centre

The Spanish National Cancer Research Centre Carlos III Foundation (CNIO) is an institution at the cutting edge of oncology research. Since its inception in 1998, and after more than 14 years of scientific activity, the CNIO has created a legacy of scientific research excellence and is recognised today as one of the top leading Cancer Research Centres in the world.

At CNIO, around 400 researchers at the forefront of global science, strive to better understand the underlying mechanisms of cancer and to find ways to combat it.

The ultimate goal of the CNIO is to advance knowledge and foster translation of scientific breakthroughs into novel and more effective ways to prevent, diagnose and treat cancer.